CD47与胃癌相关性的研究进展(4)
[11] Zhang M，Hutter G，Kahn S A，et al.Anti-CD47 Treatment Stimulates Phagocytosis of Glioblastoma by M1 and M2 Polarized Macrophages and Promotes M1 Polarized Macrophages In Vivo[J].PLoS One，2016，11(4)：e0153550.
[12] Barclay A N，Brown M H.The SIRP family of receptors and immune regulation[J].Nature Reviews Immunology，2006，6(6)：457.
[13] Zhao X W，Beek E M V，Schornagel K，et al.CD47-signal regulatory protein-α(SIRPα) interactions form a barrier for antibody-mediated tumor cell destruction[J].Proceedings of the National Academy of Sciences of the United States of America，2011，108(45)：18342.
, http://www.100md.com
[14] Yi T，Li J，Chen H，et al.Splenic Dendritic Cells Survey Red Blood Cells for Missing Self-CD47 to Trigger Adaptive Immune Responses[J].Immunity，2015，43(4)：764.
[15] Liu X，Yang P，Cron K，et al.CD47 blockade triggers T cell-mediated destruction of immunogenic tumors[J].Nature Medicine，2015，21(10)：1209.
[16] Uluckan O，Becker S N，Deng H，et al.CD47 regulates bonemass and tumor metasis to bone[J].Cancer Res，2009，69(7)：3196-3204.
, 百拇医药
[17] Ran L，Wei H，Peng G，et al.CD47 promotes ovarian cancer progression by inhibiting macrophage phagocytosis[J].Oncotarget，2017，8(24)：39021-39032.
[18] Nagahara M，Mimori K，Kataoka A，et al.Correlated expression of CD47 and SIRPA in bone marrow and in peripheral blood predicts recurrence in breast cancer patients[J].Clinical Cancer Research An Official Journal of the American Association for Cancer Research，2010，16(18)：4625-4635.
, http://www.100md.com [19] Xu J F，Pan X H，Zhang S J，et al.CD47 blockade inhibits tumor progression human osteosarcoma in xenograft models[J].Oncotarget，2015，6(27)：23662-23670.
[20] Zhang Y，Sime W，Juhas M，et al.Crosstalk between colon cancer cells and macrophages via inflammatory mediators and CD47 promotes tumour cell migration[J].European Journal of Cancer，2013，49(15)：3320-3334.
[21] Cioffi M，Trabulo S，Hidalgo M，et al.Inhibition of CD47 Effectively Targets Pancreatic Cancer Stem Cells via Dual Mechanisms[J].Clinical Cancer Research An Official Journal of the American Association for Cancer Research，2015，21(10)：2325-2337.
, 百拇医药
[22] Roberts D D，Kaur S，Soto-Pantoja D R.Therapeutic targeting of the thrombospondin-1 receptor CD47 to treat liver cancer[J].J Cell Commun Signal，2015，9(1)：101-102.
[23]甘波，楊乐莹，李媛媛，等.CD47和SIRPa1在胃癌组织中的表达和意义[C]//首届浙赣两省肿瘤研究交流会论文汇编.2012.
[24] Yoshida K，Tsujimoto H，Matsumura K，et al.CD47 is an adverse prognostic factor and a therapeutic target in gastric cancer[J].Cancer Medicine，2015，4(9)：1322-1333., 百拇医药(谭观桥 吴立鹏 张建文)
[12] Barclay A N，Brown M H.The SIRP family of receptors and immune regulation[J].Nature Reviews Immunology，2006，6(6)：457.
[13] Zhao X W，Beek E M V，Schornagel K，et al.CD47-signal regulatory protein-α(SIRPα) interactions form a barrier for antibody-mediated tumor cell destruction[J].Proceedings of the National Academy of Sciences of the United States of America，2011，108(45)：18342.
, http://www.100md.com
[14] Yi T，Li J，Chen H，et al.Splenic Dendritic Cells Survey Red Blood Cells for Missing Self-CD47 to Trigger Adaptive Immune Responses[J].Immunity，2015，43(4)：764.
[15] Liu X，Yang P，Cron K，et al.CD47 blockade triggers T cell-mediated destruction of immunogenic tumors[J].Nature Medicine，2015，21(10)：1209.
[16] Uluckan O，Becker S N，Deng H，et al.CD47 regulates bonemass and tumor metasis to bone[J].Cancer Res，2009，69(7)：3196-3204.
, 百拇医药
[17] Ran L，Wei H，Peng G，et al.CD47 promotes ovarian cancer progression by inhibiting macrophage phagocytosis[J].Oncotarget，2017，8(24)：39021-39032.
[18] Nagahara M，Mimori K，Kataoka A，et al.Correlated expression of CD47 and SIRPA in bone marrow and in peripheral blood predicts recurrence in breast cancer patients[J].Clinical Cancer Research An Official Journal of the American Association for Cancer Research，2010，16(18)：4625-4635.
, http://www.100md.com [19] Xu J F，Pan X H，Zhang S J，et al.CD47 blockade inhibits tumor progression human osteosarcoma in xenograft models[J].Oncotarget，2015，6(27)：23662-23670.
[20] Zhang Y，Sime W，Juhas M，et al.Crosstalk between colon cancer cells and macrophages via inflammatory mediators and CD47 promotes tumour cell migration[J].European Journal of Cancer，2013，49(15)：3320-3334.
[21] Cioffi M，Trabulo S，Hidalgo M，et al.Inhibition of CD47 Effectively Targets Pancreatic Cancer Stem Cells via Dual Mechanisms[J].Clinical Cancer Research An Official Journal of the American Association for Cancer Research，2015，21(10)：2325-2337.
, 百拇医药
[22] Roberts D D，Kaur S，Soto-Pantoja D R.Therapeutic targeting of the thrombospondin-1 receptor CD47 to treat liver cancer[J].J Cell Commun Signal，2015，9(1)：101-102.
[23]甘波，楊乐莹，李媛媛，等.CD47和SIRPa1在胃癌组织中的表达和意义[C]//首届浙赣两省肿瘤研究交流会论文汇编.2012.
[24] Yoshida K，Tsujimoto H，Matsumura K，et al.CD47 is an adverse prognostic factor and a therapeutic target in gastric cancer[J].Cancer Medicine，2015，4(9)：1322-1333., 百拇医药(谭观桥 吴立鹏 张建文)